Prevention of cardiovascular events in elderly hypercholesterolemic patients

Current Atherosclerosis Reports

Volumn 1, Issue 1, 1999, Pages 9-15

  Bruckert, Eric ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cholesterol Level; Coronary Heart Disease; Major Coronary Event; Multiple Risk Factor Intervention Trial; Pravastatin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

AGED; CARDIOVASCULAR DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; REVIEW; RISK FACTOR;

AGED; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; RISK FACTORS;

EID: 0033157042     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-999-0044-4     Document Type: Article

References (50)

1. Thompson GR: To treat or not to treat dyslipidemia in the asymptomatic elderly. In Vascular Disease in the Elderly. Edited by Lakatta EG. New York: Parthenon Publishing Group Ltd; 1998:105–115.
2. Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J Am Med Assoc 1993, 269:3015–3023. DOI: 10.1001/jama.269.23.3015
3. American College of Physicians: Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med 1996, 124:515–517.
4. Uemura K: International trends in cardiovascular diseases in the elderly. Eur Heart J 1988, 9(suppl D):1–8.
5. Feinllieb M, Gillum RF: Coronary heart disease in the elderly: the magnitude of the problem in the United States. In Coronary Heart Disease in the Elderly. Edited by Wenger NK, Furberg CD, Pitt E. New York: Elsevier; 1986:29–59.
6. Castelli WP, Wilson PW, Levy D, Anderson K: Cardiovascular risk factors in the elderly. Am J Cardiol 1989, 63:12H-19H. DOI: 10.1016/0002-9149(89)90110-0
7. Vokonas PS, Kannel WB: Epidemiology of coronary heart disease in the elderly. In Cardiovascular Disease in the Elderly Patient. Edited by Tresh DD, Aronow WS. New York: Marcel Dekker, Inc.; 1993: 91–123.
8. Maggioni AP, Maseri A, Fresco C, et al.: Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI-2). N Engl J Med 1993, 329:1442–1448. DOI: 10.1056/NEJM199311113292002
9. The Italian Longitudinal Study on Aging Working Group: Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. Int J Epidemiol 1997, 26:995–1002. DOI: 10.1093/ije/26.5.995
10. Giroud M, Beuriat P, Gisselmann A, et al.: Epidémiologie des accidents vasculaires cérébraux. D’après le registre dijonnais (1985–1988). Presse Med 1989, 18:1103–1106.
11. Amery A, Birkenhager W, Brixko P, et al.: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985, 1:1349–1354. DOI: 10.1016/S0140-6736(85)91783-0
12. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255–3264. DOI: 10.1001/jama.265.24.3255
13. Stamler J, Wentworth D, Neaton JD, for the MRFIT Research Group. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986, 256:2823–2888. DOI: 10.1001/jama.256.20.2823
14. Manolio TA, Pearson TA, Wenger NK, et al.: Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol 1992, 2:161–176. DOI: 10.1016/1047-2797(92)90051-Q
15. Anderson KM, Castelli WP, Levy D: Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA 1987, 257:2176–2180. DOI: 10.1001/jama.257.16.2176
16. Harris T, Cook EF, Kannel WB, Goldman L: Proportional hazards analysis of risk factors for coronary disease in individuals aged 65 or older. The Framingham Heart Study. J Am Geriatr Soc 1988, 36:1023–1028.
17. Gordon DJ, Rifkind BM: Treating high blood cholesterol in the older patient. Am J Cardiol 1989, 63:48H-52H. DOI: 10.1016/0002-9149(89)90116-1
18. Benfante R, Reed D: Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 1990, 263:393–396. DOI: 10.1001/jama.263.3.393
19. Shipley MJ, Pocock SJ, Marmot MG: Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. Br Med J 1991, 303:88–92.
20. Agner E, Hansen PF: Fasting serum cholesterol and triglycerides in a ten-year prospective study in old age. Acta Med Scand 1983, 214:33–41. DOI: 10.1111/j.0954-6820.1983.tb08567.x
21. Barrett-Connor E, Suarez L, Khaw K, et al.: Ischemic heart disease risk factors after age 50. J Chronic Dis 1984, 37:903–913. DOI: 10.1016/0021-9681(84)90066-3
22. Zimetbaum P, Frishman W, Ooi WL, et al.: Relationship between plasma lipids and the incidence of cardiovascular events in the old old: the Bronx longitudinal aging study. Circulation 1990, 82(suppl III):619.
23. Forette B, Tortat D, Wolmark Y: Cholesterol as risk factor for mortality in elderly women. Lancet 1989, 1:868–870. DOI: 10.1016/S0140-6736(89)92865-1
24. Rudman D, Mattson DE, Nagraj HS, et al.: Prognostic significance of serum cholesterol in nursing home men. J Parenter Enter Nutr 1988, 12:155–158. DOI: 10.1177/0148607188012002155
25. Fried LP, Kronmal RA, Newman AB, et al.: Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998, 279:585–592. DOI: 10.1001/jama.279.8.585
26. Corti MC, Guralnik JM, Salive ME, et al.: Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 1997, 126:753–760.
27. Miller NE: Why does plasma low density lipoprotein concentration in adults increase with age? Lancet 1984, 1:263–267. DOI: 10.1016/S0140-6736(84)90135-1
28. Kannel WB: Nutritional contributors to cardiovascular disease in the elderly. J Am Geriatr Soc 1986, 34:27–36.
29. Hollander D, Morgan D: Increase in cholesterol intestinal absorption with aging in the rat. Exp Gerontol 1979, 14:201–204. DOI: 10.1016/0531-5565(79)90020-2
30. Grundy SM, Vega GL, Bilheimer DW: Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age. Arteriosclerosis 1985, 5:623–630.
31. Elahi VK, Elahi D, Andres R, et al.: A longitudinal study of nutritional intake in men. J Gerontol 1983, 38:162–180.
32. Shock NW, Greulich RC, Andres R, et al.: Normal human aging: the Baltimore Longitudinal Aging Study. Bethesda: National Institutes of Health; 1984:84–2450.
33. Kreisberg RA, Kasim S: Cholesterol metabolism and aging. Am J Med 1987, 82:54–60. DOI: 10.1016/0002-9343(87)90272-5
34. Rudman D, Mattson DE, Nagraj HS, et al.: Antecedents of death in the men of a Veterans Administration Nursing Home. J Am Geriatr Soc 1987, 35:496–502.
35. Grant MD, Piotrowski ZH, Miles TP: Declining cholesterol and mortality in a sample of older Nursing Home Residents. J Am Geriatr Soc 1996, 44:31–36.
36. Ettinger WH Jr, Harris T, Verdery RB, et al.: Evidence for inflammation as a cause of hypocholesterolemia in older people. J Am Geriatr Soc 1995, 43:264–266.
37. Scandinavian Simvastatin Survival Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994, 344:1383–1389. DOI: 10.1016/S0140-6736(94)90566-5
38. Sacks FM, Pfeffer MA, Moyé LA, et al.: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996, 335:1001–1009. DOI: 10.1056/NEJM199610033351401
39. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998, 339:1349–1357. DOI: 10.1056/NEJM199811053391902
40. Shepherd J, Cobbe SM, Ford I, et al.: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995, 333:1301–1307. DOI: 10.1056/NEJM199511163332001
41. Downs JR, Clearfield M, Weis S, et al.: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 1998, 279:1615–1622. DOI: 10.1001/jama.279.20.1615
42. Denke MA: Drug treatment of hyperlipidemia in elderly patients. Curr Opin Lipidol 1993, 4:56–62. DOI: 10.1097/00041433-199302000-00010
43. Lewis SJ, Moyé LA, Sacks FM, et al.: Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med 1998, 129:681–689.
44. Miettinen TA, Pyorala K, Olsson AG, et al.: Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 1997, 96:4211–4218.
45. Ramsay LE, Haq IU, Jackson PR, et al.: Targeting lipid-lowering drug therapy for primary prevention of coronary heart disease: an updated Sheffield table. Lancet 1996, 348:387–388. DOI: 10.1016/S0140-6736(96)05516-X
46. Santanello NC, Barber BL, Applegate WB, et al.: Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction In Seniors Program (CRISP) pilot study. J Am Geriatr Soc 1997, 45:8–14.
47. Bruckert E, Giral P, Salloum J, et al.: Carotid stenosis is a powerful predictor of a positive exercise electrocardiogram in a large hyperlipidemic population. Atherosclerosis 1992, 92:105–114. DOI: 10.1016/0021-9150(92)90269-M
48. Lentzner HR, Pamuk ER, Rhodenhiser EP, et al.: The quality of life in the year before death. Am J Public Health 1992, 82:1093–1098. DOI: 10.2105/AJPH.82.8.1093
49. Vita AJ, Terry RB, Hubert HB, Fries JF: Aging, health risks, and cumulative disability. N Engl J Med 1998, 338:1035–1041. DOI: 10.1056/NEJM199804093381506
50. Shepherd J, Blauw G, Murphy M: The PROSPER design: a prospective study of pravastatin in the elderly at risk. In Drugs Affecting Lipid Metabolism. Edited by Paoletti R. Milan: Fondazione Giovanni Lorenzini; 1998:108.